Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chuqi Lei

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Scientific Reports|November 6, 2025
SERPINA1 gene regulates the tumorigenesis and progression of breast cancer through PI3K/AKT signaling pathway and tumor immune microenvironmentChuqi Lei, Wei Lu, Yuan Li, et al.
Journal of Cancer|April 5, 2024
PD-1/PD-L1 Inhibitor - Related Adverse Events and Their Management in Breast CancerChuqi Lei, Xiangyi Kong, Yuan Li, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|March 12, 2021
Multi-center investigation of breast reconstruction after mastectomy from Chinese Society of Breast Surgery: A survey based on 31 tertiary hospitals (CSBrS-004)Feng Xu, Chuqi Lei, Heng Cao, et al.
Frontiers in Oncology|May 17, 2023
AGR2: a secreted protein worthy of attention in diagnosis and treatment of breast cancerKe Zhang, Yuan Li, Xiangyi Kong, et al.
Mediators of Inflammation|March 25, 2026
Mitochondria Pathway Signature Predicts Prognosis and Therapeutic Response and Identifies REXO2 as a Crucial Regulator in Breast CancerZizhao Guo, Heng Cao, Chuqi Lei, et al.
Mediators of Inflammation|February 19, 2026
Mitochondria Pathway Signature Predicts Prognosis and Therapeutic Response and Identifies REXO2 as a Crucial Regulator in Breast CancerZizhao Guo, Heng Cao, Chuqi Lei, et al.
Nature Communications|March 16, 2025
DTIAM: a unified framework for predicting drug-target interactions, binding affinities and drug mechanismsZhangli Lu, Guoqiang Song, Huimin Zhu, et al.
Medicine|June 3, 2020
Patient satisfaction in one-stage immediate breast reconstruction after mastectomy: A multi-center comparative patient evaluation of prosthesis, LDMF, and TRAM techniquesChuqi Lei, Lijie Xu, Feng Xu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 7, 2025
Drug target proteome profiling identifies HES1-driven mitotic catastrophe in ovarian serous carcinomaJie Bao, Sanna Pikkusaari, Jun Dai, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Scientific Reports|November 6, 2025
SERPINA1 gene regulates the tumorigenesis and progression of breast cancer through PI3K/AKT signaling pathway and tumor immune microenvironmentChuqi Lei, Wei Lu, Yuan Li, et al.
Journal of Cancer|April 5, 2024
PD-1/PD-L1 Inhibitor - Related Adverse Events and Their Management in Breast CancerChuqi Lei, Xiangyi Kong, Yuan Li, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|March 12, 2021
Multi-center investigation of breast reconstruction after mastectomy from Chinese Society of Breast Surgery: A survey based on 31 tertiary hospitals (CSBrS-004)Feng Xu, Chuqi Lei, Heng Cao, et al.
Frontiers in Oncology|May 17, 2023
AGR2: a secreted protein worthy of attention in diagnosis and treatment of breast cancerKe Zhang, Yuan Li, Xiangyi Kong, et al.
Mediators of Inflammation|March 25, 2026
Mitochondria Pathway Signature Predicts Prognosis and Therapeutic Response and Identifies REXO2 as a Crucial Regulator in Breast CancerZizhao Guo, Heng Cao, Chuqi Lei, et al.
Mediators of Inflammation|February 19, 2026
Mitochondria Pathway Signature Predicts Prognosis and Therapeutic Response and Identifies REXO2 as a Crucial Regulator in Breast CancerZizhao Guo, Heng Cao, Chuqi Lei, et al.
Nature Communications|March 16, 2025
DTIAM: a unified framework for predicting drug-target interactions, binding affinities and drug mechanismsZhangli Lu, Guoqiang Song, Huimin Zhu, et al.
Medicine|June 3, 2020
Patient satisfaction in one-stage immediate breast reconstruction after mastectomy: A multi-center comparative patient evaluation of prosthesis, LDMF, and TRAM techniquesChuqi Lei, Lijie Xu, Feng Xu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 7, 2025
Drug target proteome profiling identifies HES1-driven mitotic catastrophe in ovarian serous carcinomaJie Bao, Sanna Pikkusaari, Jun Dai, et al.
Pageof 2